NOX
Click for more information
1.52% 6.7¢ noxopharm limited

News: NOX Noxopharm Proposes To Evaluate Idronoxil Use In Patients

  1. Hot News
    190,693 Posts.
    lightbulb Created with Sketch. 2793
    clock Created with Sketch.
    01/04/20
    13:05
    Post #: 43818040

    April 1 (Reuters) - Noxopharm Ltd (NOX) :

    • PROPOSES TO EVALUATE IDRONOXIL USE IN PATIENTS AT RISK OF ACUTE RESPIRATORY DISTRESS SYNDROME AND MULTI-ORGAN FAILURE DUE TO COVID-19
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
0.001(1.52%) 		Mkt cap ! $19.57M
Open High Low Value Volume
6.7¢ 6.7¢ 6.7¢ $818 12.21K

Buyers (Bids)

No. Vol. Price($)
1 17790 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 4049 1
View Market Depth
Last trade - 15.44pm 12/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.